We are live on ! Find out more
NAP

New Amsterdam Partners Portfolio holdings

AUM $272M Turnover 40.71%
1-Year Est. Return 12.21%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+12.21%
3 Year Est. Return
+73.94%
5 Year Est. Return
+120.95%
10 Year Est. Return
–
AUM
$470M
AUM Growth
+$48.1M
Cap. Flow
+$35M
Cap. Flow %
7.44%
Top 10 Hldgs %
24.35%
Holding
142
New
25
Increased
52
Reduced
39
Closed
26
Avg Time Held
1 year
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$10.6M
2
CUBI icon
Customers Bancorp
CUBI
+$7.74M
3
IOSP icon
Innospec
IOSP
+$7.47M
4
PBF icon
PBF Energy
PBF
+$6.85M
5
KNL
Knoll, Inc.
KNL
+$6.47M

Top Sells

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$8.11M
2
DLX icon
Deluxe
DLX
+$7.34M
3
AVNT icon
Avient
AVNT
+$5.65M
4
INVX icon
Innovex International
INVX
+$5.34M
5
ZD icon
Ziff Davis
ZD
+$5.26M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.65%
2 Industrials 16.99%
3 Technology 16.31%
4 Financials 13.34%
5 Healthcare 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EXLS icon
51
EXL Service
EXLS
$5.99B
$3.77M 0.8%
+339,300
New +$3.42M
2017 Q2
0 quarters
MTD icon
52
Mettler-Toledo International
MTD
$32.5B
$3.71M 0.79%
6,313
-94
-1% -$51.5K
2016 Q1
5 quarters
EPR icon
53
EPR Properties
EPR
$4.27B
$3.71M 0.79%
51,606
-805
-2% -$58.7K
2017 Q1
1 quarter
NSIT icon
54
Insight Enterprises
NSIT
$4.71B
$3.52M 0.75%
+88,112
New +$3.72M
2017 Q2
0 quarters
SIVB
55
DELISTED
SVB Financial Group
SIVB
$3.33M 0.71%
18,953
-3,148
-14% -$564K
2016 Q1
5 quarters
EBS icon
56
Emergent Biosolutions
EBS
$327M
$3.33M 0.71%
+98,228
New +$3.03M
2017 Q2
0 quarters
ARW icon
57
Arrow Electronics
ARW
$10.9B
$3.3M 0.7%
42,132
+35,520
+537% +$2.65M
2013 Q3
15 quarters
ANIK icon
58
Anika Therapeutics
ANIK
$267M
$3.23M 0.69%
65,536
+9,939
+18% +$458K
2016 Q4
2 quarters
KLXI
59
DELISTED
KLX Inc.
KLXI
$3.18M 0.68%
+75,459
New +$3.06M
2017 Q2
0 quarters
TREX icon
60
Trex
TREX
$4.66B
$3.14M 0.67%
185,824
-3,832
-2% -$64.7K
2015 Q2
8 quarters
TGNA icon
61
DELISTED
TEGNA Inc
TGNA
$3.02M 0.64%
209,821
-124,676
-37% -$1.92M
2017 Q1
1 quarter
OME
62
DELISTED
Omega Protein
OME
$2.82M 0.6%
157,523
+22,960
+17% +$429K
2016 Q2
4 quarters
GPK icon
63
Graphic Packaging
GPK
$2.54B
$2.79M 0.59%
202,836
-193,022
-49% -$2.59M
2017 Q1
1 quarter
MMS icon
64
Maximus
MMS
$3.22B
$2.71M 0.58%
43,345
+7,356
+20% +$457K
2017 Q1
1 quarter
ACET icon
65
DELISTED
Aceto Corp
ACET
$2.67M 0.57%
172,628
+26,578
+18% +$396K
2016 Q4
2 quarters
PKOH icon
66
Park-Ohio Holdings
PKOH
$663M
$2.64M 0.56%
69,364
+10,748
+18% +$403K
2017 Q1
1 quarter
CRS icon
67
Carpenter Technology
CRS
$18.7B
$2.63M 0.56%
+70,129
New +$2.6M
2017 Q2
0 quarters
IPAR icon
68
Interparfums
IPAR
$3.71B
$2.56M 0.54%
69,745
-1,901
-3% -$68.3K
2014 Q1
13 quarters
AAN.A icon
69
DELISTED
The Aaron's Company Inc Class A
AAN.A
$2.51M 0.53%
+64,576
New +$2.51M
2017 Q2
0 quarters
CBRE icon
70
CBRE Group
CBRE
$38.5B
$2.41M 0.51%
66,276
-754
-1% -$26.2K
2016 Q1
5 quarters
PCH icon
71
DELISTED
PotlatchDeltic
PCH
$2.41M 0.51%
+52,709
New +$2.42M
2017 Q2
0 quarters
COR icon
72
Cencora
COR
$65.1B
$2.4M 0.51%
25,355
-713
-3% -$63.5K
2013 Q2
16 quarters
GXP
73
DELISTED
Great Plains Energy Incorporated
GXP
$2.34M 0.5%
80,039
-948
-1% -$27.6K
2016 Q4
2 quarters
APO icon
74
Apollo Global Management
APO
$65.4B
$2.32M 0.49%
87,579
+843
+1% +$22.5K
2017 Q1
1 quarter
WSM icon
75
Williams-Sonoma
WSM
$29.5B
$2.29M 0.49%
94,300
-2,876
-3% -$73.4K
2016 Q3
3 quarters

Similar funds

New Amsterdam Partners's Q2 2017 Portfolio in Review

As of Q2 2017, New Amsterdam Partners held 142 positions worth $470M, up 11% from $422M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New Amsterdam Partners deployed $35M of net new capital in Q2 2017, opening 25 new positions and adding to 52 existing holdings. Its largest new stake was Manhattan Associates: 224,089 shares worth $10.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Innovex International, an estimated $5.34M trimmed.

  • New Amsterdam Partners's largest Q2 2017 buy was Manhattan Associates: 224,089 shares worth $10.8M.
  • New Amsterdam Partners added most to Innospec in Q2 2017, an estimated $7.47M increase.
  • New Amsterdam Partners's biggest Q2 2017 reduction was Innovex International, cutting an estimated $5.34M.
  • New Amsterdam Partners fully exited Strategy Inc in Q2 2017, selling an estimated $8.11M.
  • New Amsterdam Partners's ten largest holdings make up 24% of its $470M portfolio in Q2 2017.
  • New Amsterdam Partners opened 25 new positions and closed 26 in Q2 2017.
  • New Amsterdam Partners's portfolio value rose 11% quarter-over-quarter to $470M.

Based on New Amsterdam Partners's 13F filing for Q2 2017, filed 2 Aug 2017.